International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease
Main Authors: | Williamson, K, Lytvyak, E, De Krijger, M, Trivedi, P, Estes, D, Yu, L, Pratt, D, De Vries, A, Daretti, L, Liu, C, Bowlus, C, Marschall, H, Montano-Loza, A, Chapman, R, Van Der Woude, C, Marzioni, M, Keshav, S, Ponsioen, C, Hirschfield, G, Levy, C |
---|---|
Format: | Conference item |
Published: |
Elsevier
2018
|
Similar Items
-
Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases
by: Lynch, K, et al.
Published: (2019) -
Primary sclerosing cholangitis.
by: Williamson, K, et al.
Published: (2014) -
Prognostic Significance of Severe Vitamin D Deficiency in Patients with Primary Sclerosing Cholangitis
by: Maryam Ebadi, et al.
Published: (2023-01-01) -
Primary sclerosing cholangitis: A review and update
by: James H. Tabibian, et al.
Published: (2017-12-01) -
A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
by: de Vries, E, et al.
Published: (2017)